Studies of biochemical parameters in breast cancer with and without metastasis

Indian Journal of Clinical Biochemistry

Volumn 19, Issue 1, 2004, Pages 71-75

  Mishra, Sandhya ^a   Sharma, D C ^a   Sharma, Praveen ^a  

^a SMS MEDICAL COLLEGE   (India)

Author keywords

Alkaline phosphatase; Carcinoma breast; Diagnostic tools; Ferritin; Gamma glutamyl transpeptidase; Glutathione; Lactate dehydrogenase; Metastasis

Indexed keywords

ALKALINE PHOSPHATASE; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER PATIENT; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS;

EID: 1342301740     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02872394     Document Type: Article

References (28)

1. Sharma, B.K. and Ray, A. (2000) Breast and Prostate Cancer. IJCB, 15, (Suppl.), 110-17.
2. Linblom, A. and Liljegreen, A. (2000) Tumor markers in malignancies. B.M.J., 320, 424-27.
3. Burti's, C.A. and Ashwood, E.R. (1994) Tietz textbook of clinical chemistry. Second edition, W.B. Saunders Company, Philadelphia pp. 814-15, 831, 848-49, 897-99.
4. Sadig, R.E.E. and Lai, L.C. (2000) Oestrogens and breast cancer. Clin. Biochemist. Rev., 21, 93-99
5. Beutler, E. (1971) Red cell metabolism: A manual of biochemical methods. Grune and Stration. New York, 103-5.
6. Worwood, M. (1986) Serum Ferritin. Clin. Sci. 70, 215-20.
7. Dacie, J.V. and Lewis, S.M. (1994) Practical haematology, Churchill Livingston, Edinburgh, 8th ed., pp. 49-82.
8. Guner, G., Kirkali, G., Yenisey, C., Tore, I.R. (1992) Cytosol and Serum ferritin in breast carcinoma. Cancer Lett. Dec. 24, 67 (2-3), 103-12.
9. Perquin, M., Oster, T., Maul, A., Froment, N., Untereiner, M. and Bagrel, D. (2001) The Glutathione related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features. J. Can. Res. Clin. Oncol. 127 (6), 368-74.
10. Aboughalia, A.H. and Fouad, I.M. (2000) Glutathione and its metabolizing enzymes in patients with different benign and malignant diseases. Clin. Biochem. 33 (8), 657-62.
11. Kher, A., Maghe, G. and Deshpande, A. (1997) Significance of serum ferritin and lactate dehydrogenase in benign and malignant disease of breast. Indian J. Pathol. Microbiol. 40 (3), 321-6.
12. Albuquer que, K.V., Price, M.R., Badley, R.A., Jonrup, I., Pearson, D., Blamey, R.W. and Robertson, J.F. (1995) Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survival. Eur. J. Surg. Oncol. 21 (5), 504-9.
13. Letiagin, V.P. and Vysotskaia, I.V. (1995) Tumor marker CE A, CA 15-3, MCA, TPA, Ferritin and PTH in the diagnosis and monitoring of primary breast cancer. Vestin Ross Akad Med Nauk, 4, 10-14.
14. Aydiner, A., Topuz, E., Disci, R., Yasasever, V., Dincer, M., Dincol, K. and Bilge, N. (1994) Serum Tumor marker for detection of bone metastasis in breast cancer patients. Acta Oncol, 33 (2), 181-86.
15. Kokocinska, D., Widala, E., Donocik, J. and Nolewajka, E. (1999) The value of evaluating tumor markers: CA15-3 and ferritin in blood serum of patients grouped as "high risk" for breast cancer. Przegl Lek. 56 (10), 664-67.
16. Elliott, R.L., Elliott, M.C., Wang, F. and Head, J.F. (1993) Breast carcinoma and the role of iron metabolism. A cytochemical tissue, culture, and ultrastructural study. Ann. N.Y. Acad. Sci. 698, 159-66.
17. Devlin, T.M. (1997) Textbook of Biochemistry with clinical correlations. Fourth ed. Wiley - Liss. New York p. 484.
18. Sharabasy, M.M., Dosoky, I., Horia, H. and Khalaf, A.H. (1993) Elevation of glutathione, glutathione reductase and nucleic acids in both normal tissues and tumor of breast cancer patients. Cancer Lett. 72, 11-15.
19. Murray, G.I., Burke, M.D. and Ewen, S.W.B. (1987) Glutathione localization in benign and malignant human breast lesions. Br. J. Cancer 55, 605-9.
20. Sieger, S., Bose, C.P., Younes, H., Thies, E. Hoppenkamp, S.R. and Younes, E. (1984) Glutathione and GSH dependent enzymes in the tumours and non-tumours mucosa of the human colon and rectum. J. Cancer Res. Clin. Oncol. 107, 288-340.
21. Beutler, E. and Gelbart (1985). Plasma glutathione in health and in patients with malignant disease. J. Lab. Clin. Med. 105, 581-84.
22. Kumaraguruparan, R., Subapriya, R., Kabalimoorthy, J. and Nagini, S. (2002) Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin. Biochem. 35 (4), 275-79.
23. Vaid, P. and Sharma, D.C. (1974) a clinico biochemical study of phosphohexose isomerase, allesterase and SH group. Ind. J. Can. Dec., 448-50.
24. Vanhoof, V.O., Vanoostrom, A.T., Lepoutre, L.G. and DeBroe, M.E. (1992) Alkaline phosphates isoenzyme patterns in malignancy disease. Clin. Chem. 38, 2546-2551.
25. Stieber, P., Mangal, D., Ritzke, C., Rossler, N., Kirsch, C.M. and Eiermann, W. (1992) Significance of bone alkaline phosphatase. CA15-3 and CEA in detection of bone metastasis during follow up of patients suffering from breast carcinoma. Eur. J. Clin. Chem. Clin. Biochem. 30, 809-14.
26. Ramaswamy, G., Rao, V.R., Krishnamoorthy, L., Ramesh, G., Gomathy, R. and Renukadevi, D. (2000) Serum levels of bone alkaline phosphatase in breast and prostate cancer with bone metastasis. Indian J. Clin. Biochem. 15 (2), 110-13.
27. Lamerz, R., Stieber, P. and Fateh-Moghadam, A. (1993) Serum marker combinations in human breast cancer (review). In Vivo, 7 (613), 607-13.
28. Sharma, D.C., Mishra, S. and Sharma, P. (2001) Blood Glutathione level in breast cancer patients before and after surgery. J. Obst. Gyn. India. 51 (6), 150-51.